About Us

The Team

Ariel Weigler

CEO

Brings experience in R&D efforts, project management and team leadership in the medical-device industry.

Holds a B.Sc and M.Sc in biomedical engineering from the Technion, Israeli institute of technology.

Dr. Yair Feld

Founder and CMO

Interventional cardiologist, 15+ years experience. Founder of CorAssist, Nephera, Paragate Medical, ProArc, Cuspa and Genegrafts.

Ofer Pillar

Industry expert

An experienced entrepreneur. For the past 30 years has been involved in the establishment and management of several medical devices. Chairman of the investment committee of NGT3 fund and incubator.

Zohar Gendler

Chariman of the board

CEO & Managing Partner of NGT3 VC. Led the establishment and investment in more than 50 companies such as Prolor Biotech (sold to OPKO for $480M), Mazor Robotics (sold to Medtronic for $1.6B), ReWalk (NASDAQ: RWLK), Corindus (sold to Siemens Healthcare for $1.1B), and many others.

Dr. Amir Toren

CTO

Ph.D in Biochemistry and Microbiology from the department of Molecular Microbiology and Biotechnology, Tel Aviv University. Spanning a career of over 15 years, Amir brings extensive experience from the pharmaceutical industry of managing and developing multidisciplinary teams.

Nizar Mashal

CFO

Manages the finances of NGT portfolio companies with strong leadership.

Involved in fund-raising processes, negotiations and complex transactions.

Yaron Tal

Executive Director

Managing partner of Cognum innovation with 25 years of experience as CEO,COO and CFO in public and private medical companies as TAG Dream medical, Rainbow Medical, T.A.G. Medical Products ,Corassisit cardiovascular, Top Spin Medical Inc, Galil Medical, Elron Electronic, Prof. Itzhak Swary & Co.

Dr. David Yakobi

MD, Medical Advisor

Dr. David Yakobi, MD is a Board Certified Cardiac Surgeon and specialist in Cardiology, Intensive Care, Emergency Medicine, Hemodynamics, and Physiology. Dr. Yakobi has vast experience in Coronary Artery Disease (CAD), Valvular disease, and Pediatric congenital heart disease. He also plays a key role as a medical consultant to major startup companies in the healthcare industry with particular emphasis on medical devices and digital-health.

Scientific Advisory Board

Dr. Harindra Wijeysundera

MD, PhD

Interventional Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre from Toronto.

Prof. Felix Mahfoud

Associate professor of Internal Medicine andCardiology at Saarland University Hospital in Hamburg Germany Affiliate/Visiting Professor of the Harvard-MIT,Biomedical Engineering, Boston, MA

Prof. Jozef Bartunek

MD, Phd

Associate Director at Cardiovascular Center, Aalst, OLV Hospital, Belgium. Medical Advisor

Prof. Giora Weisz

Interventional Cardiologist at Columbia University in the City of New York